SPRINKLR, INC. (CXM)
Sprinklr Appoints Jordi Ribas to Board of Directors
NERVGEN PHARMA CORP. (NGEN)
NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
CREATIVE REALITIES, INC. (CREX)
Creative Realities Reports Fiscal 2026 Second Quarter Results
ABEONA THERAPEUTICS INC. (ABEO)
Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
ASCENDIS PHARMA A/S (ASND)
Ascendis Pharma Reports Second Quarter 2026 Financial Results
KARYOPHARM THERAPEUTICS INC. (KPTI)
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
COLLEGIUM PHARMACEUTICAL, INC (COLL)
Collegium Announces $50 Million Accelerated Share Repurchase Program
ADC THERAPEUTICS SA (ADCT)
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
REBORN COFFEE, INC. (REBN)
Reborn Coffee Signs $20 Million Annual Supply Agreement with The Mighty Oak, Strengthening Its Revenue Base and Profitability Through the Conversion of Existing Supply Volume
UTSTARCOM HOLDINGS CORP. (UTSI)
UTStarcom Announces Finance Leadership Changes